HSPA2 and non-small cell lung carcinoma: In general, our results showed that neither the isoform-specific reduction of HSPA1 or HSPA2 expression nor double knockdown of HSPA1 and HSPA2 elevated sensitivity of NSCLC cells to BTZ.